Copperwynd Financial »

Vertex Pharmaceuticals Incorporated shares owned by Copperwynd Financial

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Copperwynd Financial from 13F filings

Historical chart of Copperwynd Financial investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Copperwynd Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Copperwynd Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 4.8k 418.01
2023-09-30 $1.6M 4.6k 347.74
2023-06-30 $1.6M 4.6k 351.91
2023-03-31 $1.5M 4.7k 315.07
2022-12-31 $1.4M 4.7k 288.78
2022-09-30 $1.3M 4.5k 289.63
2022-06-30 $1.3M 4.6k 281.79

More positions owned by Copperwynd Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard World Mega Grwth Ind (MGK)
Glacier Ban (GBCI)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Schwab Charles Family Amt Tax Free Mny (SCTXX)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Meta Platforms Cl A (META)

View all positions for Copperwynd Financial

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated